Growth Metrics

Pfizer (PFE) Dividends payables Growth (1y) (2010 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.33%
Jun 29, 2025 2.73%
Dec 31, 2024 2.74%
Jun 30, 2024 2.81%
Dec 31, 2023 3.00%
Jul 2, 2023 3.12%
Dec 31, 2022 2.40%
Oct 2, 2022 2.46%
Jul 3, 2022 2.79%
Dec 31, 2021 4.02%
Oct 3, 2021 3.74%
Jul 4, 2021 3.46%
Dec 31, 2020 2.76%
Sep 27, 2020 6.02%
Jun 28, 2020 6.03%
Dec 31, 2019 2.78%
Sep 29, 2019 1.48%
Jun 30, 2019 0.56%
Dec 31, 2018 0.89%
Sep 30, 2018 2.83%
Jul 1, 2018 3.99%
Dec 31, 2017 4.37%
Oct 1, 2017 4.83%
Jul 2, 2017 4.62%
Dec 31, 2016 4.97%
Oct 2, 2016 5.38%
Jul 3, 2016 5.45%
Dec 31, 2015 8.24%
Jun 28, 2015 4.61%
Dec 31, 2014 2.89%
Jun 29, 2014 -2.08%
Mar 30, 2014 -80.00%
Dec 31, 2013 -4.04%
Sep 29, 2013 0.00%
Jun 30, 2013 -7.72%
Mar 31, 2013 400.00%
Dec 31, 2012 -3.51%
Jul 1, 2012 11.55%
Apr 1, 2012 0.00%
Dec 31, 2011 12.18%
Jul 3, 2011 12.90%
Apr 3, 2011 0.00%
Dec 31, 2010 10.11%
Oct 3, 2010 0.00%
Jul 4, 2010 34.14%